Validity Diagnostics
Validity Diagnostics (Vision Diagnostics, Inc.) manufactures and sells proprietary 2nd Generation Specimen Validity Testing reagents and controls that detect 18 classes of urine adulterants, including synthetic urine, for clinical and forensic drug testing laboratories running Beckman AU Series analyzers.
- Company typePrivate
- Founded2015
- HeadquartersBranford, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Validity Diagnostics firmographics
Firmographics- Name
- Validity Diagnostics
- Legal name
- Vision Diagnostics, Inc.
- Website
- https://vdxcares.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Validity Diagnostics (Vision Diagnostics, Inc.) manufactures and sells proprietary 2nd Generation Specimen Validity Testing reagents and controls that detect 18 classes of urine adulterants, including synthetic urine, for clinical and forensic drug testing laboratories running Beckman AU Series analyzers.
- Ownership category
- akta.pro rank
Validity Diagnostics industry classification
Industry- Product category
- Clinical Diagnostic Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industries
- Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL), Urinalysis & Routine Screening Diagnostics (HLAHAAAG), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
Keywords
Where Validity Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Branford
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Validity Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Drug Testing Reagents and Consumables: Validity Diagnostics generates revenue through the sale of laboratory reagents, calibrators, and controls for drugs of abuse testing. Their product portfolio includes urine creatinine reagents, oxidant history reagents, pH screening reagents, specific gravity reagents, and True Urine detection reagents. These are consumable products used on automated chemistry analyzers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise/Laboratory Quote Pricing |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Validity Diagnostics product offering
Product offeringCore offering
Validity Diagnostics manufactures and sells 2nd Generation Specimen Validity Testing (SVT) reagents, calibrators, and controls used on standard high-speed immunoassay chemistry analyzers such as the Beckman AU Series. The portfolio includes urine creatinine, oxidant history, pH screening, specific gravity, and True Urine long- and short-duration reagents that together detect 18 classes of urine subversion including synthetic urine, dilution, adulteration, and substitution.
Product overview
Validity Diagnostics (VDx) offers the 2nd Generation Specimen Validity Test (SVT) Panel, a comprehensive portfolio of laboratory reagents, calibrators, and controls for drugs of abuse testing on standard high-speed immunoassay analyzers. The product line includes four core testing reagent categories: Urine Creatinine reagents (for detecting specimen dilution), Oxidant History reagents (for detecting adulteration), pH Screening reagents (for detecting chemical manipulation), Specific Gravity Screening reagents (for detecting diluted specimens), and True Urine Long/Short Duration reagents (for detecting synthetic urine substitution). The 2nd Generation SVT Panel detects 18 different classes of adulterants and substitution techniques compared to only 2 classes detectable by legacy first-generation 5-test panels. Products are designed for use on Beckman AU Series chemistry analyzers and are offered in multiple formats including standard test kits (1600 tests), reagent-only packs, and bulk 1-liter kits (up to 10,000 tests) for high-volume laboratories.
Differentiator
Problem solved
Functional benefit
Products and services
- 2nd Generation SVT Panel A comprehensive 5-test specimen validity testing panel designed to detect 18 different classes of urine subversion including synthetic urine, dilution, adulteration, and substitution. Sold to clinical laboratories, hospitals, pain management clinics, drug rehabilitation centers, criminal justice agencies, and physician offices for use on Beckman AU Series chemistry analyzers.
- Urine Creatinine Reagents
Quantifiable outcome
- 16% of samples failed SVT Panel vs. 5% with classic trio method (creatinine, pH, specific gravity)
- +1 more outcomes
Companies that use Validity Diagnostics
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles3 records
Validity Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Validity Diagnostics partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights3 records
Validity Diagnostics competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Validity Diagnostics social profiles
Digital presenceValidity Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Validity Diagnostics leadership team
Management profileNumber of profiles
Profiles9 records
Validity Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Validity Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Validity Diagnostics
What does Validity Diagnostics do?
Validity Diagnostics manufactures and sells 2nd Generation Specimen Validity Testing (SVT) reagents, calibrators, and controls used on standard high-speed immunoassay chemistry analyzers such as the Beckman AU Series. The portfolio includes urine creatinine, oxidant history, pH screening, specific gravity, and True Urine long- and short-duration reagents that together detect 18 classes of urine subversion including synthetic urine, dilution, adulteration, and substitution.
Is Validity Diagnostics a public or private company?
Validity Diagnostics is a private company. It is classified as family owned and is currently operating.
When was Validity Diagnostics founded?
Validity Diagnostics was founded in 2015. It employs 1 to 10 people.
Where is Validity Diagnostics based?
Validity Diagnostics is headquartered in Branford, United States, in the North America region.
How does Validity Diagnostics make money?
One revenue line is on record: drug Testing Reagents and Consumables.
Does Validity Diagnostics have an API?
No public API is recorded for Validity Diagnostics.
What industry is Validity Diagnostics in?
Validity Diagnostics's product category is Clinical Diagnostic Reagents. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAHAAAL, Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables). Its NAICS code is 325413 and its SIC code is 2835.